# DEFB4A

## Overview
The DEFB4A gene encodes the protein defensin beta 4A, also known as human beta-defensin 2 (hBD-2), which is a member of the defensin family of antimicrobial peptides. These peptides are integral to the innate immune system, providing a first line of defense against a broad spectrum of pathogens, including bacteria, viruses, fungi, and parasites. Defensin beta 4A is primarily expressed in epithelial cells and is characterized by its ability to disrupt microbial membranes, a function facilitated by its structural features such as alpha-helices and beta-sheets, and stabilized by disulfide bonds. The protein also plays a role in modulating immune responses by interacting with receptors like CCR6 and binding to complement components, thereby influencing inflammatory pathways and immune cell recruitment (Cieślik2021Human; Abubakar2020Relative). Variations in the DEFB4A gene have been linked to several inflammatory and immune-related conditions, underscoring its clinical significance in diseases such as asthma, Crohn's disease, and psoriasis (Hollox2007Psoriasis; Fellermann2006A; Borchers2021Human).

## Structure
The DEFB4A gene encodes the human beta-defensin 4A protein, which is part of the defensin family known for its antimicrobial properties. The primary structure of DEFB4A consists of a sequence of amino acids that form the protein chain. This sequence is crucial for the protein's function and interaction with microbial membranes.

In terms of secondary structure, DEFB4A typically includes alpha-helices and beta-sheets, which contribute to the protein's stability and functionality. These structural elements are common in defensins and play a role in their ability to disrupt microbial cell membranes.

The tertiary structure of DEFB4A involves the overall three-dimensional folding of the protein, which is stabilized by disulfide bonds. These bonds are essential for maintaining the protein's structural integrity and are characteristic of the defensin family.

The quaternary structure of DEFB4A may involve dimerization or interaction with other proteins, which can enhance its antimicrobial activity. Post-translational modifications such as glycosylation and proteolytic cleavage can occur, potentially affecting the protein's stability and function. These modifications are important for the protein's maturation and activity in the human body.

## Function
The DEFB4A gene encodes human β-defensin 2 (hBD-2), a small antimicrobial peptide that plays a crucial role in the innate immune response. hBD-2 is primarily expressed in epithelial cells and is involved in defending against a wide range of pathogens, including Gram-negative and Gram-positive bacteria, viruses, fungi, and parasites (Cieślik2021Human). It is secreted by epithelial cells in response to microbial contact or pro-inflammatory cytokines, and its expression is regulated by transcription factors such as NF-κB and AP-1 (Cieślik2021Human).

hBD-2 functions by modulating immune signaling pathways and inflammatory responses. It acts chemotactically by interacting with the CCR6 receptor, recruiting immune cells like memory T-cells and immature dendritic cells (Cieślik2021Human). Additionally, hBD-2 binds to the complement component C1q, inhibiting the classical complement activation pathway, which may help prevent uncontrolled activation of the innate immune response (Cieślik2021Human).

In the context of infections, hBD-2 enhances the integrity of epithelial barriers and maintains a balance between pathogenic and commensal bacteria (Cieślik2021Human). It is also involved in tissue repair and regeneration, as seen in its role in stimulating corneal epithelial cell migration and proliferation (Abubakar2020Relative).

## Clinical Significance
Mutations and alterations in the DEFB4A gene, which encodes human beta-defensin 4A, have been associated with several inflammatory and immune-related conditions. Variations in the DEFB4A gene, including single nucleotide polymorphisms (SNPs) and copy number variations (CNVs), have been linked to asthma and atopy in children. Specific mutations, such as rs6651513 and rs543538872, are associated with asthma and allergy outcomes, potentially due to their influence on gene expression in the lungs (Borchers2021Human).

In Crohn's disease, particularly colonic Crohn's disease, a lower copy number of the DEFB4A gene is associated with an increased risk. This reduced copy number likely leads to diminished expression of beta-defensins, contributing to the chronic inflammation characteristic of the disease (Fellermann2006A).

The DEFB4A gene is also implicated in psoriasis, where increased genomic copy numbers are associated with a higher risk of developing the condition. This association is thought to be due to the pro-inflammatory nature of beta-defensins, which may exacerbate the inflammatory processes in psoriasis (Hollox2007Psoriasis). These findings highlight the role of DEFB4A in modulating immune responses and its potential impact on various inflammatory diseases.


## References


[1. (Hollox2007Psoriasis) Edward J Hollox, Ulrike Huffmeier, Patrick L J M Zeeuwen, Raquel Palla, Jesús Lascorz, Diana Rodijk-Olthuis, Peter C M van de Kerkhof, Heiko Traupe, Gys de Jongh, Martin den Heijer, André Reis, John A L Armour, and Joost Schalkwijk. Psoriasis is associated with increased β-defensin genomic copy number. Nature Genetics, 40(1):23–25, December 2007. URL: http://dx.doi.org/10.1038/ng.2007.48, doi:10.1038/ng.2007.48. This article has 507 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ng.2007.48)

[2. (Cieślik2021Human) Martyna Cieślik, Natalia Bagińska, Andrzej Górski, and Ewa Jończyk-Matysiak. Human β-defensin 2 and its postulated role in modulation of the immune response. Cells, 10(11):2991, November 2021. URL: http://dx.doi.org/10.3390/cells10112991, doi:10.3390/cells10112991. This article has 33 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cells10112991)

[3. (Fellermann2006A) Klaus Fellermann, Daniel E. Stange, Elke Schaeffeler, Hartmut Schmalzl, Jan Wehkamp, Charles L. Bevins, Walter Reinisch, Alexander Teml, Matthias Schwab, Peter Lichter, Bernhard Radlwimmer, and Eduard F. Stange. A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to crohn disease of the colon. The American Journal of Human Genetics, 79(3):439–448, September 2006. URL: http://dx.doi.org/10.1086/505915, doi:10.1086/505915. This article has 392 citations.](https://doi.org/10.1086/505915)

[4. (Abubakar2020Relative) Sa’adatu Abubakar, Muhammad Isa, Nazri Omar, and Sheau Tan. Relative quantification of human β‑defensins gene expression in pterygium and normal conjunctiva samples. Molecular Medicine Reports, 22(6):4931–4937, October 2020. URL: http://dx.doi.org/10.3892/mmr.2020.11560, doi:10.3892/mmr.2020.11560. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/mmr.2020.11560)

[5. (Borchers2021Human) Natascha S. Borchers, Elisangela Santos-Valente, Antoaneta A. Toncheva, Jan Wehkamp, Andre Franke, Vincent D. Gaertner, Peter Nordkild, Jon Genuneit, Benjamin A. H. Jensen, and Michael Kabesch. Human β-defensin 2 mutations are associated with asthma and atopy in children and its application prevents atopic asthma in a mouse model. Frontiers in Immunology, February 2021. URL: http://dx.doi.org/10.3389/fimmu.2021.636061, doi:10.3389/fimmu.2021.636061. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2021.636061)